Pluri Inc. Warrant, Exercise Price, Increase
Pluri Inc. (PLUR) had Warrant, Exercise Price, Increase of $5.93 per share as of 2024-04-30, per its 10-K filed 2024-09-18.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:WarrantExercisePriceIncrease · last filed 2024-09-18
- 2024-04-30: Warrant, Exercise Price, Increase $5.93.
- 2022-12-27: Warrant, Exercise Price, Increase $8.96; Warrant, Exercise Price, Increase as first filed $1.12.
- 2022-12-19: Warrant, Exercise Price, Increase $8.72; Warrant, Exercise Price, Increase as first filed $1.09.
- 2022-12-15: Warrant, Exercise Price, Increase $8.48; Warrant, Exercise Price, Increase as first filed $1.06.
| Period end | Warrant, Exercise Price, Increase | Warrant, Exercise Price, Increase as first filed |
|---|---|---|
| 2024-04-30 | $5.93 10-K · filed 2024-09-18 | |
| 2022-12-27 | $8.96 10-K · filed 2024-09-18 | $1.12 10-Q · filed 2024-02-12 |
| 2022-12-19 | $8.72 10-K · filed 2024-09-18 | $1.09 10-Q · filed 2024-02-12 |
| 2022-12-15 | $8.48 10-K · filed 2024-09-18 | $1.06 10-Q · filed 2024-02-12 |
| 2022-12-14 | $8.40 10-K · filed 2024-09-18 | $1.05 10-Q · filed 2024-02-12 |
| 2022-12-13 | $8.24 10-K · filed 2024-09-18 | $1.03 10-Q · filed 2024-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |